Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Sleep disordered breathing and the impact of nocturnal non-invasive ventilatory support on quality of life in motor neurone disease
ISRCTN ISRCTN76330611
ClinicalTrials.gov identifier
Public title Sleep disordered breathing and the impact of nocturnal non-invasive ventilatory support on quality of life in motor neurone disease
Scientific title
Acronym N/A
Serial number at source RRCC804F res/1808/7002
Study hypothesis 1. Early intervention with non-invasive ventilation will improve quality of life, survival and respiratory function in patients with motor neurone disease.
2. Domiciliary non-invasive ventilation in patients with motor neurone disease will not increase the stain experienced by the primary carer.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Nervous system diseases: motor neurone disease
Participants - inclusion criteria Patients with motor neurone disease under 75 years of age and without other serious illnesses.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 10/01/2000
Anticipated end date 10/01/2002
Status of trial Completed
Patient information material
Target number of participants Added December 2008: 102
Interventions 1. Early intervention with non-invasive ventilation
2. Standard care
Primary outcome measure(s) Quality of life
1. Generic instrument: Short Form 36
2. Specific instruments: Chronic Respiratory Disease Index, Sleep Apnoea Quality of Life Index, Epworth Sleepiness Scale
Secondary outcome measure(s) 1. Survival
2. Impact on primary carer: Care Givers Strain Index
3. Hospital admissions
4. Respiratory function: Vital capacity, maximum static mouth pressures, sniff nasal inspiratory pressure
Sources of funding NHS Executive Northern and Yorkshire (UK)
Trial website
Publications 2006 results in http://www.ncbi.nlm.nih.gov/pubmed/16426990
Contact name Dr  Stephen  Bourke
  Address NHS Northern & Yorkshire Regional Office
Postgraduate Institute South Tyneside
10-12 Framlington Place
  City/town Newcastle upon Tyne
  Zip/Postcode NE2 4AB
  Country United Kingdom
  Tel +44 0191 284 311
  Email
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 23/01/2004
Last edited 08/12/2008
Date ISRCTN assigned 23/01/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central